Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

AlixPartners

- PMLiVE

Pfizer appoints chief scientific officer

Dr Ole Isacson will lead the neuroscience research unit

Silence Therapeutics adds to leadership team

Dr Dmitry Samarsky and Dr Andy Richards join

- PMLiVE

Former Boehringer diabetes marketing VP joins Gelesis

Dr David Pass takes up the chief operating officer position

- PMLiVE

Daiichi Sankyo promotes Dr Marielle Cohard-Radice

She becomes executive vice president, global head of development

- PMLiVE

Proteostasis Therapeutics strengthens leadership team

James DeTore, Geoffrey Gilmartin and Marija Zecevic join

- PMLiVE

Repositive appoints scientific lead

Manuel Corpas joins the genome software company

Kirsten Drejer steps down as Symphogen CEO

The biotech’s CFO Martin Olin succeeds her in the role

EFPIA director general Richard Bergström resigns

Will remain in the role until a successor has been selected

- PMLiVE

Medicines Discovery Catapult appoints CEO

Chris Molloy will take up the lead role in November this year

- PMLiVE

Dr Olivier Danos joins TxCell scientific advisory board

He currently serves as cell and gene therapy SVP at Biogen

- PMLiVE

Owlstone Medical bolsters management team

Chris Hodkinson, Dr Marc van der Schee and Hamilton Scanlon join

- PMLiVE

imc appoints London and Toronto managing directors

Graeme Reay and Dr Azhar Rana join the med comms agency

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links